From clinical development and commercialization to capital formation and M&A, we evaluate the factors influencing company valuations, financing requirements, and strategic transactions.
Therapeutics
Clinical-Stage & Commercial-Stage Biopharma
Specialty Pharmaceuticals & Biologics
Cell & Gene Therapies
MedTech & Diagnostics
Medical Devices, Surgical Technologies & Robotics
Molecular Diagnostics & Point-of-Care Testing
Diagnostic Imaging & Digital Diagnostics
Life Sciences Tools
Genomics, Proteomics & Molecular Analysis
Laboratory Instruments & Automation
Research Reagents & Consumables
Manufacturing
Contract Development & Manufacturing (CDMO)
Contract Research Organizations (CRO)
Medical Device & Pharmaceutical Manufacturing